TABLE 1.
Metabolic parameters stratified by age group
| Subjects stratified by age group |
|||||
|---|---|---|---|---|---|
| All Patients | 2–5 | 6–9 | ≥10 | p value | |
| Number of Patients | 784 | 93 | 209 | 482 | |
| Male, % (N/T) | 45.2% (354/784) | 50.5% (47/93) | 40.7% (85/209) | 46.1% (222/482) | 0.229 |
| Race, % (N/T) | 0.192 | ||||
| White | 65.8% (516/784) | 63.4% (59/93) | 63.6% (133/209) | 67.2% (324/482) | |
| African American | 17.7% (139/784) | 16.1% (15/93) | 15.3% (32/209) | 19.1% (92/482) | |
| Hispanic | 7.9% (62/784) | 9.7% (9/93) | 12.0% (25/209) | 5.8% (28/482) | |
| Other | 8.5% (67/784) | 10.7% (10/93) | 9.1% (19/209) | 7.9% (37/482) | |
| County, % (N/T) | 0.519 | ||||
| Metro | 51.4% (399/777) | 45.1% (41/91) | 51.5% (106/206) | 52.5% (252/480) | |
| Adjacent | 19.9% (155/777) | 26.4% (24/91) | 20.4% (42/206) | 18.5% (89/480) | |
| Rural | 28.7% (223/777) | 28.6 (26/91) | 28.2% (58/206) | 29.0% (139/480) | |
| Weight, kg ± SD | 79.9 ± 34.1 | 34.2 ± 10.9 | 57.3 ± 14.7 | 98.6 ± 28.3 | <0.001 |
| Height, cm ± SD | 149.0 ± 20.0 | 110.9 ± 9.7 | 137.5 ± 8.9 | 161.3 ± 10.6 | <0.001 |
| Obesity class, % (N/T) | 0.722 | ||||
| Class I, (>95%) | 15.9% (125/784) | 12.9% (12/93) | 16.3% (34/209) | 16.4% (79/482) | |
| Class II, (120–140) | 32.1% (252/784) | 30.1% (28/93) | 30.1% (63/209) | 33.4% (161/482) | |
| Class III, (>140%) | 51.9% (407/784) | 57.0% (53/93) | 53.6% (112/209) | 50.2% (242/482) | |
| Abnormal ALT, % (N/T) | 51.5% (324/629) | 52.6% (40/76) | 54.4% (98/180) | 49.9% (186/373) | 0.588 |
| Dyslipidaemia, % (N/T) | 68.1% (453/665) | 62.3 (48/77) | 70.7% (133/188) | 68.0 (272/400) | 0.410 |
| Increased BP, % (N/T) | 31.1% (187/600) | 27.7% (18/65) | 17.2% (27/157) | 37.6% (142/378) | <0.001 |
| Diabetes risk, % (N/T) | 33.8% (233/690) | 18.2% (14/77) | 30.4% (58/191) | 38.2% (161/422) | 0.002 |
Note: % represents the percent of the patients in the specific group, N represents the number of patients, where T represents total number of patients in that group. SD stands for standard deviation, ALT stands for alanine aminotransferase. Dyslipidaemia is defined as one or more of the following: increased total cholesterol, high LDL cholesterol, elevated triglycerides or low HDL cholesterol. Increased blood pressure was defined as having pre-hypertension or hypertension by auscultatory measurements. Diabetes risk was defined as having pre-diabetes or diabetes.